Reporter SARS-CoV-2 Vector Assembly for Korean Isolate Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing full-length clone of SARS coronavirus 2 is derived from an early phase isolate, lacking representation of the Korean isolate YS006, which has distinct nucleotide and amino acid changes affecting host cell entry efficiency, transmissibility, and pathogenicity, hindering research on phenotype changes and drug effectiveness.
Innovation Solution
A method to produce a full-length clone of the Korean isolate SARS coronavirus 2 YS006 by constructing a BAC vector and sequentially inserting cDNA fragments, followed by inserting a reporter gene, to create a recombinant vector that maintains infectivity and replication capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a full-length clone of early phase SARS-COV-2 isolate is used, then the clone is readily available, but it cannot represent the distinct nucleotide and amino acid changes of the Korean isolate YS006 affecting host cell entry efficiency, transmissibility, and pathogenicity
Solution Approach 1:
The full-length cDNA of SARS-COV-2 YS006 is divided into four fragments (SfoI-PmeI, PmeI-MluI, MluI-BamHI, BamHI-StuI) that are separately cloned into a BAC vector. This segmentation enables the construction of a complete clone representing the Korean isolate's distinct nucleotide and amino acid changes while maintaining the feasibility of the cloning process through modular assembly.
Solution Approach 2:
The BAC vector is prepared in advance with appropriate restriction sites and cloning elements before the cDNA fragments are inserted. This preliminary preparation of the vector backbone with pre-configured restriction enzyme sites (SfoI, PmeI, MluI, BamHI, StuI) facilitates the subsequent sequential insertion of the four cDNA fragments, ensuring the final clone accurately represents the YS006 isolate characteristics.
2Adaptability or versatility
If the Korean isolate YS006 full-length clone is constructed, then it enables research on phenotype changes and drug effectiveness, but the construction process requires multiple cDNA fragments and BAC vector assembly
Solution Approach 1:
The BAC vector serves multiple functions: it acts as the cloning vehicle for the four cDNA fragments, provides a stable platform for maintaining the complete YS006 genome, enables expression of the viral proteins, and facilitates various research applications including phenotype analysis, drug effectiveness evaluation, and transmission studies. This multi-functionality justifies the constructed complexity.
Solution Approach 2:
By dividing the full-length cDNA into four manageable fragments with specific restriction sites, the complex task of cloning the entire YS006 genome is broken down into sequential, controllable steps. Each fragment can be independently prepared and then assembled into the BAC vector, making the overall process more manageable while maintaining the completeness and accuracy of the final clone for diverse research applications.
3Productivity
If reporter genes are inserted into the recombinant vector, then rapid quantitative evaluation of antiviral drug effectiveness and neutralizing antibody titers is enabled, but the vector construction becomes more complex
Solution Approach 1:
The reporter gene (such as luciferase or fluorescent protein) is merged with the YS006 viral genome within the BAC vector, creating a chimeric recombinant virus. This combination allows the reporter expression to be coupled with viral replication and infection processes, enabling rapid quantitative evaluation of antiviral drug effectiveness and neutralizing antibody titers through simple luminescence or fluorescence assays without adding significant complexity to the overall vector construction.
Solution Approach 2:
The insertion of fluorescent or luminescent reporter genes introduces detectable optical signals (color changes or light emission) that allow real-time, quantitative monitoring of viral infection, replication, and response to antiviral drugs. This optical detection capability dramatically accelerates the evaluation process compared to traditional methods, as the reporter signal provides immediate feedback on drug effectiveness and antibody neutralization activity.
Data Source
AI summary
There are SARS coronavirus 2 recombinant vectors derived from a GH clade SARS coronavirus 2 Korean isolate, which express distinct reporter genes, and the production method thereof. A full-length clone of a SARS coronavirus 2 Korean isolate or a derivative thereof, according to one embodiment, can be used as a standard material for evaluating the efficacy of therapeutic agents and vaccines in cell lines and animal models while maintaining infectivity and replication capacity when restored to viruses, can be used to develop a large-scale testing method for therapeutic agent development, and can be used to develop attenuated vaccine strains. In addition, a SARS coronavirus 2 recombinant vector derived from a Korean isolate or a derivative thereof, expressing a reporter gene, can be used for high-capacity, rapid drug screening in the development of antibody therapeutic agents and antiviral agents.